AVTE   $2.55  -3.41% Market Closed After Close 2.55 0.0

Aerovate Therapeutics Inc
Total Cash 104.20M
totalCashPerShare 3.61
EBITDA -94.11M
Total Debt 681.00K
quickRatio 6.122
currentRatio 6.508
Total Revenue
debtToEquity 0.721
Revenue/Share
ROA -0.44035
ROE -0.74421
grossProfits
freeCashflow -44.86M
operatingCashflow -74.52M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -23.85M
forwardPE -2.76
floatShares 11.85M
sharesOutstanding 28.87M
sharesShort 664.99K
sharesShortPriorMonth 1.07M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.01%
Short Ratio help_outline 2.99%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 3.271
Price To Book help_outline 0.84
earningsQuarterlyGrowth
netIncomeToCommon -87.94M
trailingEps -3.13%
forwardEps -1.00%
enterpriseToEbitda 0.25
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 120
lastUpdated Nov. 7, 2024, 5:09 a.m.